Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) stock performance was -2.98% in last session and finished the day at $8.47. Traded volume was 69,618.00million shares … Continue reading Biotech Insider Buying: OvaScience Inc (NASDAQ:OVAS), BioTime (NYSEMKT:BTX), Insys Therapeutics (NASDAQ:INSY), Novavax (NASDAQ:NVAX), ImmuCell Corporation (NASDAQ:ICCC)

Jason Knox06/2006/20

Biotech Bullish Stocks: ImmuCell Corporation (NASDAQ:ICCC), TG Therapeutics, Inc. (NASDAQ:TGTX), Relypsa Inc (NASDAQ:RLYP), OHR Pharmaceutical Inc (NASDAQ:OHRP)

ImmuCell Corporation (NASDAQ:ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2014. For the first quarter ended March 31, 2014, ImmuCell Corporation (NASDAQ:ICCC) reported a product sales increase of 13% to $2.08 million versus $1.85 million in the … Continue reading Biotech Bullish Stocks: ImmuCell Corporation (NASDAQ:ICCC), TG Therapeutics, Inc. (NASDAQ:TGTX), Relypsa Inc (NASDAQ:RLYP), OHR Pharmaceutical Inc (NASDAQ:OHRP)

Mark DeFrance05/1605/16